Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. (603707)

Overview

Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd., established in 2000 and headquartered in Nanjing, China, is a prominent company focused on the research and development, manufacture, and distribution of pharmaceutical products and active pharmaceutical ingredients (APIs) within the Chinese market. The company has carved a niche for itself in the pharmaceutical industry through its comprehensive range of high-quality drugs and APIs, catering to various medical needs and conditions.

Products and Services

Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd. offers an extensive portfolio of pharmaceutical products, including but not limited to:

• Heparin Sodium, Enoxaparin Sodium, Dalteparin Sodium, Nadroparin Calcium: These anticoagulant medications help prevent and treat blood clots, offering options for various clinical needs.
• Atracurium, Cisatracurium: Used in anesthesia, these muscle relaxants facilitate intubation and mechanical ventilation during surgical procedures.
• Fulvestrant, Doxercalciferol: Used in the treatment of hormone receptor-positive metastatic breast cancer and secondary hyperparathyroidism in patients with chronic kidney disease, respectively.
• Milrinone Lactate, Fondaparinux Sodium: Heart failure treatment and prevention of venous thromboembolism are the focus of these medications, respectively.
• Phenylephrine, Gemcitabine: A nasal decongestant and a chemotherapeutic agent for various cancers highlight the company’s range in addressing different therapeutic areas.
• Levoleucovorin, Carboplatin: These are used in cancer treatment, with applications in diminishing side effects and as a chemotherapy drug, respectively.
• Several cancer, anesthesia, and critical care drugs: Including but not limited to Cytarabine, Bleomycin, Topotecan Hydrochloride, Bendamustine HCL, Bortezomib, Clofarabine, Busulfan, Dactinomycin, Azacitidine, Mycophenolate Mofetil, Tigecycline, Glycopyrrolate, Melphalan, Daptomycin, Decitabine, Haloperidol Decanoate, Carmustine, Bivalirudin, Dexmedetomidine, and Neostigmine Methylsulfate injections, addressing a wide spectrum of medical needs.
• Additional offerings: Isosulfan Blue, Succinylcholine Chloride, Furosemide, Regadenoson, Voriconazole, Ganirelix Acetate, Eptifibatide, Mitomycin, Vancomycin, Micafungin Sodium, Docetaxel, Nelarabine, Pemetrexed, Rocuronium Bromide, Zoledronic Acid, Thiamine, Fluorouracil, Perixafor, Thiotepa, Pantoprazole Sodium, Glatiramer Acetate, and Bupivacaine Hydrochloride injections. This diverse array extends the company's reach into numerous therapeutic areas, including surgery, cardiology, oncology, and more, with each product designed to meet the highest standards of quality and efficacy.